Cargando…
Clinical phenotype in scleroderma patients based on autoantibodies
OBJECTIVE: We aimed to characterize the clinical phenotype of patients with SSc based on autoantibodies (topoisomerase antibody (Scl-70), ACA and ANA). METHODS: We included patients with SSc who fulfilled the 2013 ACR/EULAR criteria, with disease duration ≤15 years. Six groups of patients were defin...
Autores principales: | Santos, Cristiana Sieiro, Morales, Clara Moriano, Castro, Carolina Álvarez, Álvarez, Elvira Díez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036993/ https://www.ncbi.nlm.nih.gov/pubmed/36968636 http://dx.doi.org/10.1093/rap/rkad010 |
Ejemplares similares
-
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
por: Santos, Cristiana Sieiro, et al.
Publicado: (2021) -
Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases
por: Sieiro Santos, Cristiana, et al.
Publicado: (2022) -
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
por: Santos, C. Sieiro, et al.
Publicado: (2020) -
Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
por: Clark, Kristina E. N., et al.
Publicado: (2022) -
The clinical relevance of autoantibodies in scleroderma
por: Ho, Khanh T, et al.
Publicado: (2003)